Loading…
Sika Interplant Systems (SIKA)₹903.80−1.61%Aerospace & Defense
In the Jun 2026 quarter (consolidated), Sika Interplant Systems reported sales of ₹42.78 Cr, down 37.0% from Jun 2025, and net profit of ₹8.42 Cr, down 18.9% year on year. For the year to Mar 2026, sales were ₹211 Cr and net profit ₹36.12 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.23 | 25.95 | 37.09 | 30.37 | 33.16 | 37.90 | 45.91 | 67.91 | 51.53 | 50.19 | 41.28 | 42.78 |
| Expenses | 14.45 | 20.70 | 30.66 | 24.35 | 26.46 | 30.25 | 38.18 | 55.66 | 41.05 | 38.85 | 31.01 | 34.61 |
| Operating Profit | 3.85 | 5.37 | 6.58 | 6.14 | 6.87 | 7.82 | 7.95 | 12.48 | 10.63 | 11.59 | 10.41 | 8.34 |
| OPM % | 21.2% | 20.7% | 17.7% | 20.3% | 20.8% | 20.6% | 17.3% | 18.4% | 20.6% | 23.1% | 25.3% | 19.5% |
| Other Income | 3.04 | 1.29 | 1.25 | 1.16 | 1.31 | 1.32 | 2.28 | 1.75 | 1.48 | 1.45 | 0.49 | 2.53 |
| Interest | 0.03 | 0.09 | 0.07 | 0.03 | 0.06 | 0.03 | 0.16 | 0.15 | 0.12 | 0.08 | 0.14 | 0.20 |
| Depreciation | 0.15 | 0.25 | 0.20 | 0.20 | 0.24 | 0.28 | 0.31 | 0.24 | 0.25 | 0.25 | 0.27 | 0.32 |
| Profit before tax | 6.69 | 6.30 | 7.54 | 7.03 | 7.86 | 8.81 | 9.74 | 13.82 | 11.69 | 12.65 | 10.44 | 10.30 |
| Tax % | 25.2% | 25.3% | 19.9% | 25.2% | 21.4% | 19.1% | 19.0% | 25.2% | 23.8% | 25.1% | 25.2% | 18.6% |
| Exceptional items | 0.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 5.02 | 4.74 | 6.07 | 5.28 | 6.19 | 7.16 | 7.92 | 10.38 | 8.97 | 9.52 | 7.86 | 8.42 |
| EPS (Rs) | 2.38 | 2.25 | 2.86 | 2.50 | 2.93 | 3.38 | 3.75 | 4.90 | 4.24 | 4.50 | 3.71 | 3.98 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.96 | 33.95 | 21.95 | 45.92 | 62.88 | 79.91 | 97.86 | 59.94 | 106 | 148 | 211 | 186 |
| Expenses | 39.14 | 32.09 | 20.07 | 39.12 | 54.17 | 65.20 | 78.26 | 50.18 | 86.26 | 119 | 167 | 146 |
| Operating Profit | 2.99 | 2.99 | 1.99 | 5.99 | 8.99 | 14.99 | 19.98 | 9.98 | 19.99 | 28.99 | 44.97 | 40.97 |
| OPM % | 7.0% | 8.0% | 10.0% | 13.1% | 15.1% | 18.1% | 20.0% | 17.0% | 19.0% | 20.0% | 21.1% | 22.1% |
| Other Income | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 3.01 | 3.01 | 7.02 | 6.02 | 5.01 | 5.95 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.54 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.09 |
| Profit before tax | 2.99 | 2.99 | 1.99 | 5.99 | 8.98 | 15.96 | 21.94 | 11.97 | 24.92 | 32.93 | 48.84 | 45.08 |
| Tax % | 36.0% | 34.0% | 24.9% | 29.0% | 23.0% | 25.0% | 26.0% | 28.0% | 23.9% | 22.9% | 24.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.05 | 0.05 | −0.17 | 0.23 | 0.07 | 0.26 | 1.10 | 0.36 | 1.33 | 0.00 |
| Net Profit | 2.01 | 2.01 | 1.01 | 4.01 | 7.01 | 12.03 | 17.05 | 9.02 | 19.06 | 25.05 | 36.12 | 34.77 |
| EPS (Rs) | 0.83 | 0.96 | 0.71 | 2.02 | 3.34 | 5.64 | 7.86 | 4.17 | 9.17 | 12.00 | 17.27 | 16.43 |
| Dividend payout % | 19.0% | 17.0% | 23.0% | 8.0% | 7.0% | 14.0% | 10.0% | 19.0% | 22.0% | 20.0% | 20.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.00 | 3.99 | 4.00 | 3.99 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.01 | 4.01 | 4.01 |
| Reserves | 34.90 | 35.87 | 37.91 | 38.88 | 41.91 | 47.93 | 59.86 | 73.80 | 80.87 | 98.92 | 120 | 151 |
| Borrowings | 3.00 | 2.99 | 2.00 | 3.00 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.98 | 12.94 | 5.97 | 3.98 | 15.92 | 16.92 | 15.92 | 19.90 | 17.92 | 18.91 | 28.86 | 19.90 |
| Total Liabilities | 43.88 | 54.79 | 49.88 | 49.85 | 63.84 | 69.86 | 80.78 | 97.70 | 103 | 122 | 153 | 175 |
| Fixed Assets | 33.89 | 34.85 | 36.89 | 36.87 | 36.87 | 36.85 | 36.88 | 35.85 | 35.87 | 42.87 | 44.85 | 43.85 |
| CWIP | 0.00 | 1.99 | 2.99 | 2.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.01 | 0.00 | 3.01 | 3.01 | 8.02 | 19.05 | 2.01 | 9.02 | 20.04 | 30.06 | 38.09 | 81.18 |
| Other Assets | 8.98 | 17.95 | 7.99 | 7.98 | 17.95 | 13.96 | 41.89 | 52.83 | 47.88 | 47.91 | 69.81 | 49.84 |
| Inventories | 1.47 | 0.92 | 1.46 | 1.72 | 3.00 | 6.63 | 3.12 | 6.75 | 9.75 | 5.14 | 7.84 | 1.25 |
| Trade receivables | 1.65 | 10.70 | 1.39 | 3.10 | 10.10 | 1.57 | 5.46 | 6.76 | 12.57 | 10.89 | 32.54 | 10.61 |
| Cash & equivalents | 4.95 | 5.54 | 3.92 | 2.47 | 4.09 | 4.43 | 29.44 | 37.61 | 23.87 | 24.45 | 24.90 | 27.51 |
| Total Assets | 43.88 | 54.79 | 49.88 | 49.85 | 63.84 | 69.86 | 80.78 | 97.70 | 103 | 122 | 153 | 175 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.99 | 2.99 | 4.99 | 0.99 | 6.98 | 10.97 | 7.98 | 15.97 | −2.99 | 19.95 | 7.98 | 46.89 |
| Cash from investing activity | −1.01 | −3.01 | −5.02 | 0.00 | −4.01 | −10.03 | −8.02 | −14.05 | 5.01 | −18.07 | −3.01 | −40.09 |
| Cash from financing activity | −0.99 | 0.00 | 0.99 | −1.99 | −0.99 | −0.99 | −0.99 | −1.99 | −1.99 | −1.99 | −3.98 | −5.98 |
| Net cash flow | −1.99 | 0.99 | 0.00 | −0.99 | 1.99 | 0.00 | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 |
| Capex | 1.10 | 3.29 | 3.04 | 0.74 | 1.52 | 0.73 | 0.43 | 0.08 | 0.60 | 8.15 | 3.57 | 0.42 |
| Free cash flow | 0.00 | 0.00 | 1.99 | 0.00 | 8.99 | 10.98 | 7.99 | 15.99 | −3.99 | 12.98 | 4.99 | 45.97 |
| CFO / OP % | 60.0% | 138.0% | 212.0% | 56.0% | 147.0% | 148.0% | 84.0% | 109.0% | 1.0% | 130.0% | 55.0% | 131.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 20 | 94 | 15 | 51 | 81 | 9 | 25 | 25 | 76 | 37 | 80 | 18 |
| Inventory days | 24 | 10 | 21 | 46 | 35 | 55 | 21 | 38 | 98 | 26 | 28 | 3 |
| Days payable | 8 | 99 | 19 | 26 | 70 | 22 | 41 | 38 | 87 | 44 | 70 | 16 |
| Cash conversion cycle | 35 | 4 | 16 | 69 | 45 | 42 | 3 | 23 | 86 | 19 | 38 | 5 |
| Working capital days | −4 | −10 | −10 | 19 | −4 | −33 | −6 | −4 | 54 | 19 | 49 | 14 |
| ROCE % | 6.0% | 7.0% | 8.0% | 5.0% | 13.1% | 19.0% | 27.0% | 31.0% | 15.1% | 26.1% | 29.0% | 35.1% |
For the Jun 2026 quarter, Sika Interplant Systems reported sales of ₹42.78 Cr, down 37.0% year on year and net profit of ₹8.42 Cr, down 18.9% year on year. The operating margin was 19.5%.
Sika Interplant Systems' sales for the year to Mar 2026 were ₹211 Cr; over the last twelve months they were ₹186 Cr.
Net profit for the year to Mar 2026 was ₹36.12 Cr, and ₹34.77 Cr over the last twelve months. Earnings per share over the same trailing period were ₹16.43.
Sika Interplant Systems reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹27.51 Cr.
Cash from operations was ₹46.89 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹45.97 Cr.